John David Hansen
Amministratore Delegato presso MABVAX THERAPEUTICS HOLDINGS, INC.
Profilo
John David Hansen is the founder of Xenerex Biosciences, which was founded in 2001.
He held the title of President & Chief Operating Officer from 2009 to 2015.
Mr. Hansen is also the founder of MabVax Therapeutics, Inc. .
Mr. Hansen's current job is as the Chief Executive & Financial Officer & Secretary at MabVax Therapeutics Holdings, Inc.Mr. Hansen's former jobs include being the President, Chief Executive Officer & Director at Telik, Inc., and the Director-Business Development & Marketing at Dura Pharmaceuticals, Inc. from 1989 to 1998.
He also served as the Senior Vice President-Corporate Development at Avanir Pharmaceuticals, Inc. from 1998 to 2006.
Mr. Hansen obtained his undergraduate degree from the University of Oregon in 1974.
Posizioni attive di John David Hansen
| Società | Posizione | Inizio |
|---|---|---|
| MABVAX THERAPEUTICS HOLDINGS, INC. | Amministratore Delegato | - |
Precedenti posizioni note di John David Hansen
| Società | Posizione | Fine |
|---|---|---|
| AVANIR PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Vendite & Marketing | 01/09/1998 |
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Amministratore Delegato | - |
MabVax Therapeutics, Inc.
 MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics, Inc. developed and commercialized immunotherapeutics for the treatment of cancer. The company was founded in 2006 and is headquartered in San Diego, CA. | Fondatore | - |
Xenerex Biosciences
 Xenerex Biosciences Miscellaneous Commercial ServicesCommercial Services Xenerex Biosciences engages in developing and commercializing human antibody products to target antigens. The company was founded by John David Hansen and Wolfgang W. Scholz and is headquartered in Aliso Viejo, CA. | Fondatore | - |
Formazione di John David Hansen
| University of Oregon | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Xenerex Biosciences
Xenerex Biosciences Miscellaneous Commercial ServicesCommercial Services Xenerex Biosciences engages in developing and commercializing human antibody products to target antigens. The company was founded by John David Hansen and Wolfgang W. Scholz and is headquartered in Aliso Viejo, CA. | Commercial Services |
Dura Pharmaceuticals, Inc.
Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Health Technology |
MabVax Therapeutics, Inc.
MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics, Inc. developed and commercialized immunotherapeutics for the treatment of cancer. The company was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Health Technology |
MabVax Therapeutics Holdings, Inc.
 MabVax Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- John David Hansen